Green Cross Corp
KRX:006280

Watchlist Manager
Green Cross Corp Logo
Green Cross Corp
KRX:006280
Watchlist
Price: 154 200 KRW 0.13% Market Closed
Market Cap: 1.8T KRW
Have any thoughts about
Green Cross Corp?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

High Profitability Stocks
Biotechnology Industry

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Green Cross Corp

Revenue
1.6T KRW
Cost of Revenue
-1.2T KRW
Gross Profit
459.3B KRW
Operating Expenses
-432.3B KRW
Operating Income
27B KRW
Other Expenses
-65.2B KRW
Net Income
-38.2B KRW

Margins Comparison
Green Cross Corp Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
KR
Green Cross Corp
KRX:006280
1.8T KRW
28%
2%
-2%
FR
Pharnext SCA
OTC:PNEXF
6T USD
0%
-17 527%
-21 040%
US
Abbvie Inc
NYSE:ABBV
352.5B USD
67%
28%
9%
US
Amgen Inc
NASDAQ:AMGN
174.8B USD
60%
19%
13%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
133.2B USD
86%
40%
-5%
US
Gilead Sciences Inc
NASDAQ:GILD
120.3B USD
78%
38%
0%
US
Epizyme Inc
F:EPE
94.1B EUR
76%
-370%
-392%
AU
CSL Ltd
ASX:CSL
137.9B AUD
52%
26%
18%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
91.2B USD
87%
30%
34%
US
Seagen Inc
F:SGT
39.3B EUR
75%
-33%
-33%
NL
argenx SE
XBRU:ARGX
33.2B EUR
89%
-22%
-14%
Country KR
Market Cap 1.8T KRW
Gross Margin
28%
Operating Margin
2%
Net Margin
-2%
Country FR
Market Cap 6T USD
Gross Margin
0%
Operating Margin
-17 527%
Net Margin
-21 040%
Country US
Market Cap 352.5B USD
Gross Margin
67%
Operating Margin
28%
Net Margin
9%
Country US
Market Cap 174.8B USD
Gross Margin
60%
Operating Margin
19%
Net Margin
13%
Country US
Market Cap 133.2B USD
Gross Margin
86%
Operating Margin
40%
Net Margin
-5%
Country US
Market Cap 120.3B USD
Gross Margin
78%
Operating Margin
38%
Net Margin
0%
Country US
Market Cap 94.1B EUR
Gross Margin
76%
Operating Margin
-370%
Net Margin
-392%
Country AU
Market Cap 137.9B AUD
Gross Margin
52%
Operating Margin
26%
Net Margin
18%
Country US
Market Cap 91.2B USD
Gross Margin
87%
Operating Margin
30%
Net Margin
34%
Country US
Market Cap 39.3B EUR
Gross Margin
75%
Operating Margin
-33%
Net Margin
-33%
Country NL
Market Cap 33.2B EUR
Gross Margin
89%
Operating Margin
-22%
Net Margin
-14%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Green Cross Corp Competitors

Country Company Market Cap ROE ROA ROCE ROIC
KR
Green Cross Corp
KRX:006280
1.8T KRW
-3%
-1%
1%
1%
FR
Pharnext SCA
OTC:PNEXF
6T USD
115%
-391%
275%
3 093%
US
Abbvie Inc
NYSE:ABBV
352.5B USD
56%
4%
15%
11%
US
Amgen Inc
NASDAQ:AMGN
174.8B USD
56%
5%
9%
10%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
133.2B USD
-3%
-2%
24%
-74%
US
Gilead Sciences Inc
NASDAQ:GILD
120.3B USD
1%
0%
23%
13%
US
Epizyme Inc
F:EPE
94.1B EUR
-877%
-67%
-73%
-182%
AU
CSL Ltd
ASX:CSL
137.9B AUD
16%
7%
12%
9%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
91.2B USD
17%
13%
13%
16%
US
Seagen Inc
F:SGT
39.3B EUR
-28%
-21%
-27%
-39%
NL
argenx SE
XBRU:ARGX
33.2B EUR
-8%
-7%
-12%
-31%
Country KR
Market Cap 1.8T KRW
ROE
-3%
ROA
-1%
ROCE
1%
ROIC
1%
Country FR
Market Cap 6T USD
ROE
115%
ROA
-391%
ROCE
275%
ROIC
3 093%
Country US
Market Cap 352.5B USD
ROE
56%
ROA
4%
ROCE
15%
ROIC
11%
Country US
Market Cap 174.8B USD
ROE
56%
ROA
5%
ROCE
9%
ROIC
10%
Country US
Market Cap 133.2B USD
ROE
-3%
ROA
-2%
ROCE
24%
ROIC
-74%
Country US
Market Cap 120.3B USD
ROE
1%
ROA
0%
ROCE
23%
ROIC
13%
Country US
Market Cap 94.1B EUR
ROE
-877%
ROA
-67%
ROCE
-73%
ROIC
-182%
Country AU
Market Cap 137.9B AUD
ROE
16%
ROA
7%
ROCE
12%
ROIC
9%
Country US
Market Cap 91.2B USD
ROE
17%
ROA
13%
ROCE
13%
ROIC
16%
Country US
Market Cap 39.3B EUR
ROE
-28%
ROA
-21%
ROCE
-27%
ROIC
-39%
Country NL
Market Cap 33.2B EUR
ROE
-8%
ROA
-7%
ROCE
-12%
ROIC
-31%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top